Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Farmasains : Jurnal Farmasi dan Ilmu Kesehatan
Dian Rahmawati
STIFA Pelita Mas Palu
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Treatment pattern and precision evaluation of diabetes mellitus therapy complications of chronic renal failure at RSUD Undata Palu Dian Rahmawati
Farmasains : Jurnal Farmasi dan Ilmu Kesehatan Vol. 5 No. 2 (2020)
Publisher : Universitas Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22219/farmasains.v5i2.14078

Abstract

Diabetes mellitus (DM) is a chronic metabolic disease or disorder characterized by high blood sugar levels accompanied by disorders of carbohydrate, protein, and lipid metabolism, which can produce chronic complications due to the inability to function insulin. Uncontrolled DM can be a risk factor for kidney failure. Abnormalities that occur in the kidneys of people with diabetes are characterized by microalbuminuria. This study aimed to determine the pattern and treatment of DM patients with Chronic renal failure or Chronic Kidney Disease (CKD) at Undata Hospital Palu, whether it is following the standard. This research is a descriptive cross-sectional study with retrospective data collection on medical records. Sampling was done using a total sampling technique with medical record data of thirty patients based on inclusion criteria. Based on the results of the study, the use of drugs in patients with DM complications of CKD was fast-acting insulin as many as twenty three people (79.3%) because insulin is the leading choice for DM patients with complications of CKD, especially in patients undergoing hemodialysis. Evaluation of treatment in patients with DM complications of CKD follows the standard treatment used as a reference. Insulin is the primary choice for diabetes mellitus patients with chronic renal failure complications, especially in patients undergoing hemodialysis.
Co-Authors